Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Entera Bio (ENTX) Profit After Tax (2018 - 2025)

Entera Bio has reported Profit After Tax over the past 8 years, most recently at -$3.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Profit After Tax fell 27.91% year-over-year to -$3.0 million, compared with a TTM value of -$11.4 million through Dec 2025, down 19.89%, and an annual FY2025 reading of -$11.4 million, down 19.89% over the prior year.
  • Profit After Tax came in at -$3.0 million for Q4 2025, up from -$3.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$2.0 million in Q4 2023 to a low of -$9.5 million in Q1 2021.
  • Median Profit After Tax over the past 5 years was -$2.8 million (2025), compared with a mean of -$3.1 million.
  • The largest YoY upside for Profit After Tax was 76.78% in 2021 against a maximum downside of 225.15% in 2021.
  • Over 5 years, Profit After Tax stood at -$4.1 million in 2021, then grew by 25.98% to -$3.0 million in 2022, then surged by 34.27% to -$2.0 million in 2023, then dropped by 18.2% to -$2.4 million in 2024, then decreased by 27.91% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Profit After Tax are -$3.0 million (Q4 2025), -$3.2 million (Q3 2025), and -$2.7 million (Q2 2025).